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he Cockayne syndrome B (CSB) protein is essential
for transcription-coupled DNA repair (TCR), which is
dependent on RNA polymerase II elongation. TCR is
required to quickly remove the cytotoxic transcription-
blocking DNA lesions. Functional GFP-tagged CSB, expressed
at physiological levels, was homogeneously dispersed through-
out the nucleoplasm in addition to bright nuclear foci and
nucleolar accumulation. Photobleaching studies showed
that GFP-CSB, as part of a high molecular weight complex,
T
 
transiently interacts with the transcription machinery. Upon
(DNA damage-induced) transcription arrest CSB binding
these interactions are prolonged, most likely reﬂecting ac-
tual engagement of CSB in TCR. These ﬁndings are consis-
tent with a model in which CSB monitors progression of
transcription by regularly probing elongation complexes
and becomes more tightly associated to these complexes
when TCR is active.
 
Introduction
 
Metabolic by-products such as reactive oxygen species, environ-
mental compounds, and short-wave electromagnetic radiation
(
 
 
 
 and UV) continuously jeopardize the DNA structure.
DNA injuries directly disturb vital DNA-transacting processes
such as replication, transcription, and cell cycle progression.
Evidence in the literature suggests that DNA damage-induced
transcriptional interference triggers apoptosis (Yamaizumi
and Sugano, 1994; Ljungman and Zhang, 1996). Our previ-
ous work on repair-deficient mice provided strong support
for our hypothesis that this damage-induced apoptosis leads
to segmental ageing (de Boer et al., 2002). Moreover, DNA
lesions may result in permanent mutations in the DNA
sequence, eventually causing cancer. To prevent the severe
consequences of genetic erosion a variety of distinct and
partially overlapping DNA repair pathways has evolved,
each specialized in the removal of specific types of damage
(Friedberg et al., 1995; Hoeijmakers, 2001). Priority is given
to remove the highly cytotoxic transcription-blocking injuries,
allowing quick resumption of transcription. This process,
referred to as transcription-coupled repair (TCR; Mellon et
al., 1987), is directly triggered by lesion-induced obstruction
of elongating RNA polymerase II (RNAP II). An example of
transcription-blocking lesions are DNA helix distorting,
UV-induced cyclo-butane pyrimidinedimers (CPDs) and
6-4 photoproducts (6-4PPs). Dependent on the type of
lesion stalled RNAP II complexes are first identified by
TCR-specific factors and further processed by the core nucleo-
tide and perhaps base excision repair (NER and BER, respec-
tively) factors (Le Page et al., 2000). Removal of lesions in
nontranscribed areas of the genome is dependent on global
genome repair (GGR).
Inherited defects within genes involved in the TCR path-
way give rise to the rare autosomal recessive disorder Cock-
ayne syndrome (CS; Venema et al., 1990; Van Hoffen et al.,
1993). CS patients display mainly progeroid symptoms,
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growth failure, and severe neurological abnormalities and are
not cancer-prone (Nance and Berry, 1992). Most of the sa-
lient clinical symptoms expressed among CS individuals, ex-
cept sun-sensitive skin, are difficult to explain by a DNA re-
pair defect only. Within classical Cockayne syndrome two
genes are involved, CSA and CSB (Troelstra et al., 1992;
Henning et al., 1995). The proteins encoded by these genes
are essential for TCR, however their exact function in this
process remains elusive. The 44-kD CSA protein contains
five WD repeats; polypeptides with these repeats are usually
involved in formation of macromolecular complexes via the
WD-repeat regions (Neer et al., 1994). The 168-kD CSB
protein is a member of the SWI2/SNF2 protein family of
putative helicases, which includes a variety of proteins in-
volved in transcriptional regulation, chromatin remodeling,
and DNA repair (Pazin and Kadonaga, 1997). Biochemical
studies showed that recombinant CSB is a DNA-dependent
ATPase and is able to remodel chromatin at the expense of
ATP (Citterio et al., 1998, 2000).
Because TCR only occurs in the presence of active tran-
scription, it was suggested that the CS proteins probably in-
teract with elongating RNA polymerase complexes. More-
over, besides a pivotal role in TCR, several lines of evidence
suggest an additional function of CS proteins, particularly
CSB, in the elongation phase of RNAP II transcription. Gel
filtration and immunoprecipitation studies showed that
CSB resides in a high molecular weight complex and that a
part of these higher order assemblies contain RNAP II (van
Gool et al., 1997). Gel mobility shift assays further revealed
that CSB interacts with a ternary complex of DNA, RNAP
II, and nascent RNA (Tantin et al., 1997) and in vitro tran-
scription experiments showed that CSB stimulates RNAP II
elongation (Selby and Sancar, 1997). In addition, Rad26
(the yeast counterpart of CSB) was found to be required for
transcription in vivo (Lee et al., 2001). Recently, in a genetic
screen for suppressor mutants of Rad26, Spt4 was identified
(Jansen et al., 2000). Spt4 is part of a protein complex
known to associate with and regulate the processivity of
RNAP II, further supporting a function of CSB in transcrip-
tion elongation (Hartzog et al., 1998; Wada et al., 1998).
A potential problem for the repair machinery is that le-
sion-stalled polymerases impede the accessibility of repair
factors to these lesions by steric hindrance (Donahue et al.,
1994). Several models have been suggested that describe
the function of the CS proteins and the fate of stalled
RNAP II complexes at lesions: (a) backtracking of the
RNAP II complex, providing access to lesions (Tornaletti
and Hanawalt, 1999); (b) pushing the elongating polymer-
ase past the lesion, translesion transcription; (c) physical
removal of the complex; (d) proteolytic degradation of the
stalled polymerase; or (e) recruiting NER proteins that
compete with RNAP II. Efforts to set up an in vitro system
for TCR have met with little success. A possible explana-
tion is that in vitro systems lack the structural elements
that are required for proper TCR function (such as nuclear
matrix attachment or chromatinated DNA). Particularly,
the topological and ATP-dependent chromatin remodeling
activity of CSB suggests a role for this protein in remodel-
ing the chromatin structure or the interaction surface of
the stalled RNAP II with DNA, to permit admission of the
NER machinery to the lesion. However, an adequate
model at which stage the TCR factors CSA and CSB are
operational is lacking.
To address some of these issues, we investigated the in-
volvement of CSB in TCR and RNAP II transcription elon-
gation in the most relevant context, the living cell. We gen-
erated a cell line that stably expresses physiologically relevant
levels of a biologically active fusion protein of the GFP and
CSB. Spatial and temporal distribution of GFP-CSB was
monitored with live cell confocal microscopy. In addition,
we determined the in vivo reaction parameters of this pro-
Figure 1. Characterization of stably expressed GFP-CSB in 
CS1AN-Sv human fibroblasts. (A) Schematic representation of GFP-
CSB fusion protein. The SNF2-like helicase domain is indicated. 
In between the GFP cDNA and the CSB open reading frame an HA 
tag is present. (B) Immunoblot analysis of GFP-CSB expression. 
Equal amounts of WCE from CS1AN-Sv, HeLa, and GFP-CSB trans-
fected CS1AN-Sv fibroblasts (two independent clones, 1 and 2 
respectively) were probed with affinity-purified polyclonal anti-CSB 
antibodies. (C) UV survival of GFP-CSB expressing fibroblasts. The 
percentage of surviving cells is plotted against the applied UV dose. 
Survival of clones 1 and 2 and control cell lines after UV treatment 
was determined by pulse labeling with [
3H]thymidine: CS1AN-Sv, 
CS-B (black open circles); VH10-Sv, wt (red open triangles), clone 1 
(green triangles), clone 2 (blue circles). Both clones show a complete 
restoration of the CS-specific UV sensitivity, indicating that the 
GFP-tagged CSB protein is fully functional. (D) Subnuclear localization 
of GFP-CSB in living stably transfected CS1AN-Sv human fibroblasts. 
All cells show a strict nuclear distribution and focal and nucleolar 
accumulations of GFP-CSB in the nucleoplasm. (E and F) Epifluorescent 
images of MRC5-Sv human fibroblasts (F) and HeLa cells (G) immuno-
stained with affinity-purified anti-CSB antibodies. Bars, 10  m. 
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tein when engaged in repair and transcription by using
FRAP analysis to measure the mobility of GFP-CSB in un-
treated transcriptionally active cells and compared these with
transcription-inhibited cells and cells challenged with a high
dose of UV light (DNA damage induction).
 
Results
 
Expression of GFP-CSB in human fibroblasts
 
To study the nuclear localization and dynamics of the CSB
protein in living cells, we tagged the protein with GFP. En-
hanced GFP was fused to the amino terminus of CSB (Fig. 1
A), resulting in a GFP-CSB fusion protein, which was stably
expressed in CSB-deficient human fibroblasts (CS1AN-Sv).
Immunoblot analysis, using anti-CSB (Fig. 1 B) and anti-
GFP (not depicted) antibodies, showed that GFP-CSB mi-
grates at the expected height of full-length fusion protein
(
 
 
 
195 kD) in two independent clones, and was expressed at
physiological levels. In addition, the GFP-CSB cDNA was
able to fully correct the UV sensitivity of CS-B cells (Fig. 1
C), stressing that GFP-CSB is functional in vivo.
 
Localization of GFP-CSB in living cells
 
Confocal microscopy demonstrated that CSB-GFP pre-
dominantly resided in the nucleus (Fig. 1 D), where it ac-
cumulated in small bright foci, in addition to a homoge-
neous distribution in the nucleoplasm. The foci were
present in a large fraction of the investigated cells in vary-
ing number and size. In addition, the fusion protein was
enriched in nucleoli (Fig. 1 D). Immunofluorescence stud-
ies in MRC5-SV and HeLa cells, using affinity-purified
polyclonal anti-CSB antibodies to determine endogenous
nontagged CSB, revealed a more disrupted focal pattern
than GFP-imaging in live cells. Immunostaining of GFP-
tagged CSB with anti-HA (GFP is tagged with HA) showed
the same disrupted pattern (unpublished data) as endoge-
nously stained CSB. From these observations, we conclude
that the disrupted foci are caused by the applied fixation
procedure. Together, these data suggest that the observed
distribution is not due to GFP-tagging or to overexpres-
sion of the protein and likely reflects the physiologically
relevant nuclear organization of CSB.
 
Nuclear mobility of GFP-CSB in living cells
 
To investigate whether GFP-CSB is bound to subnuclear
structures or is moving freely we measured the GFP-CSB
nuclear mobility and the dynamic properties of GFP-CSB
molecules by applying a FRAP protocol to the cells. Briefly,
a 2-
 
 
 
m wide strip spanning the nucleus was bleached and
fluorescence recovery in the strip was measured at 100-ms
intervals (Fig. 2 A). The rate of recovery of fluorescence in
the bleached strip is a measure for the diffusion rate of the
tagged protein (Fig. 2 B). Note that the fluorescent inten-
sity in the strip does not recover to prebleach levels (set to
one) because a fraction of the molecules is permanently
bleached. Analysis of the FRAP data revealed that the ma-
jority of GFP-CSB molecules was freely mobile in the nu-
cleoplasm with an effective diffusion coefficient (
 
D
 
eff
 
) of 7
 
 
 
m
 
2
 
/s (Fig. 2 C). In addition, the 163-kD XPF–ERCC1-
GFP complex, which is involved in the core NER reaction
(Houtsmuller et al., 1999), had a 
 
D
 
eff
 
 of 12 
 
 
 
m
 
2
 
/s, clearly
higher than that of GFP-CSB. This suggests that GFP-CSB
resides in a high MW complex (
 
 
 
800 kD), confirming our
previous gelfiltration studies with HA-tagged CSB (van
Gool et al., 1997).
 
Transient immobilization of GFP-CSB in transcription
 
Previous in vitro experiments suggest that CSB interacts
with RNAP II (Tantin et al., 1997; van Gool et al., 1997).
Therefore, we studied the dynamic behavior of GFP-CSB
molecules in relation to transcription in living cells, using a
combined FLIP/FRAP procedure (Fig. 3 A; Hoogstraten et
al., 2002). Briefly, a region at one pole of the nucleus is
bleached and the influx of fluorescence in the bleached area
is monitored (FRAP) as well as the fluorescence loss in pho-
tobleaching (FLIP) at the opposite pole of the nucleus. The
difference in relative fluorescent intensity between the FLIP
and FRAP region in time is plotted on a logarithmic scale.
The time to reach 90% redistribution of GFP-CSB fluores-
cence was 59 
 
 
 
 8 s. For comparison with other conditions
this value was set to 1 in the subsequent experiments. To in-
vestigate the relation between GFP-CSB mobility and tran-
Figure 2. FRAP analysis of GFP-CSB nuclear mobility. (A) During 
a FRAP experiment all fluorescent molecules in a small defined strip 
spanning the nucleus are bleached and subsequent fluorescent 
recovery is measured. (B) Plotting the recovery relative fluorescent 
intensity of the strip in time shows a small permanently bleached 
fraction as caused by the initial bleach pulse. The rate of fluorescent 
recovery in the strip is a measure for the effective diffusion rate 
(Deff) of a protein. (C) FRAP analysis of GFP-CSB and ERCC1-GFP–
expressing cells show a recovery of fluorescence in the strip. 
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scription we incubated cells with various transcription in-
hibitors. The transcription elongation inhibitor H8 clearly
induced a reduction in redistribution time (
 
 
 
20%) as com-
pared with transcriptionally active cells (Fig. 3 B), suggesting
a faster overall mobility of GFP-CSB molecules when tran-
scription is inhibited. In sharp contrast, the DNA-intercalat-
ing agent Actinomycin D resulted in a severe loss of the
ability for GFP-CSB molecules to redistribute, which is
indicative of a long-term immobilization of CSB proteins
(Fig. 3 C). A similar differential response to transcription in-
hibitors was reported for RNAP II, where Actinomycin D
also resulted in almost complete immobilization, whereas
the H8-like transcription inhibitor DRB led to increased
mobility (Kimura et al., 2002). It was argued by the authors
that DRB treatment results in release of RNAP II, whereas
Actinomycin D irreversibly stalls the polymerase on its tem-
plate. The similar behavior in response to transcription in-
hibitors suggests a close relationship between elongating
RNAP II and CSB in living cells. In contrast, XPF–ERCC1-
GFP was not immobilized in presence of Actinomycin D,
indicating that the immobilization of CSB is not caused by
repair activity (unpublished data).
Next, we applied the combined FLIP-FRAP procedure to
cells cultured at different temperatures. The rationale be-
hind this is that a relatively small difference in (absolute)
temperature (Kelvin) has a negligible effect on diffusion rate,
but strongly affects the duration of temperature-dependent
enzymatic processes such as transcription and active trans-
port (Phair and Misteli, 2000; Hoogstraten et al., 2002).
Combined FLIP-FRAP of GFP-CSB–expressing cells cul-
tured at respectively 37, 32, and 27
 
 
 
C revealed a significant
decrease of mobility when temperature was reduced (Fig. 3
D). In contrast, diffusion of freely mobile XPF–ERCC1-
GFP (Houtsmuller et al., 1999) did not change upon lower-
ing temperature (unpublished data). Furthermore, ATP de-
pletion by azide induced an increased GFP-CSB mobility
(Fig. 3 E).
In conclusion, these observations strongly suggest that
GFP-CSB mobility is decreased in transcriptionally active
cells by transient temperature-dependent immobilizations,
most likely due to association with elongating transcription
complexes. The fluorescence recovery plots fitted best to
curves generated by computer simulation of FRAP on mole-
cules (see Materials and methods) of which a small fraction
(
 
 
 
17%) is shortly immobilized (2–5 s).
 
CSB-associated RNAP II is transcriptionally active in vitro
 
To provide biochemical evidence for the suggested interac-
tion with the transcription machinery we isolated the CSB-
RNAP II complex as described before using our previously
generated human cell line expressing CSB tagged with a HA
epitope (HA-CSB-[His]
 
6
 
, referred to as 2tCSB; van Gool et
al., 1997) and immunoaffinity purification by binding to an
anti-HA antibody resin followed by elution with excess of
HA-peptide. Immunopurified CSB was tested in an in vitro
reconstituted transcription system (RTS) using an adeno-
virus major late promoter template (Gerard et al., 1991;
Coin et al., 1999). The HA-eluate from dtCSB whole cell
extracts (WCE) was able to support the synthesis of the 309
nt transcript when RNAP II was omitted from the RTS
(Fig. 4, compare lanes 3 and 14 with lanes 1 and 8, respec-
tively), indicating that the CSB-associated RNAP II is tran-
scriptionally active. In contrast, no signal was detected by
addition of HA-eluate from normal HeLa WCE expressing
normal CSB without HA-tag (Fig. 4, lane 5) or in the ab-
sence of any extract (Fig. 4, lane 7), supporting the specific-
ity of the CSB-RNAP II interaction. To determine the pres-
ence of additional basal transcription components in the
2tCSB HA-eluate, transcription was performed in the ab-
sence of TBP (Fig. 4, lanes 2, 4, 6, and 13), TFIIE, TFIIB,
TFIIF, or TFIIH (Fig. 4, lanes 9 to 12, respectively). In nei-
ther of these cases complementation for the lack of any of
Figure 3. Dynamic measurements of the GFP-CSB nuclear mobility 
by combined FLIP/FRAP analysis. (A) Combined FLIP/FRAP analysis 
was performed by bleaching at one pole of the nucleus and simul-
taneously monitoring the fluorescent recovery at the bleached 
(FRAP) and opposite (FLIP) poles of the cell. After bleaching, the 
FRAP curve shows a drop in fluorescent intensity followed by a 
recovery of fluorescence and the FLIP curve shows a slow decrease 
of fluorescent intensity due to redistribution of the bleached mole-
cules. The relative intensities of FLIP and FRAP were subtracted and 
plotted (y axis) against the relative redistribution time of untreated 
cells (x axis). (B) Combined FLIP/FRAP experiment of untreated cells 
(blue circles; n   10) and H8-treated cells (red diamonds; n   10). 
H8-treated cells display a decreased relative redistribution time as 
compared with untreated cells. (C) Combined FLIP/FRAP experiment 
of untreated cells (blue circles; n   10) and Actinomycin D–treated 
cells (red diamonds; n   10). Actinomycin D treatment results in an 
increased relative redistribution time as compared with untreated 
cells. (D) Combined FLIP/FRAP experiments at different temperatures 
(27 C, red triangles; 32 C, orange diamonds; and 37 C, blue circles). 
At low temperatures the relative redistribution time is increased. 
(E) Combined FLIP/FRAP experiment of untreated cells (blue circles, 
n   10) and azide-treated cells (red diamonds; n   10). Azide-treated 
cells display a decreased relative redistribution time as compared 
with untreated cells. 
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these factors was detected (Fig. 4, compare lane 2 with lane
3 and lanes 9 to 12 with lane 14), indicating that none of the
transcription initiation factors were present in the 2tCSB
(HA-elution) fraction in detectable amounts.
 
Nuclear mobility of GFP-CSB in UV-irradiated cells
 
To investigate the behavior of GFP-CSB in TCR we deter-
mined the overall nuclear mobility in UV-irradiated cells by
FRAP analysis. Fluorescence recovery plots of UV-damaged
cells (16 J/m
 
2
 
, a repair-saturating UV dose; Fig. 5 A, red
line) revealed a small but reproducible reduction of fluores-
cence recovery when compared with non-UV–damaged cells
(blue line), indicating that a fraction of GFP-CSB molecules
is immobilized for a longer period. In addition, the diffusion
rate of the mobile GFP-CSB fraction in untreated and UV-
irradiated cells is unaltered, indicating that the size of the
CSB complex is not altered upon DNA damage induction
(unpublished data).
The amount of UV-induced immobilized molecules was
proportional to UV dose: from 
 
 
 
5% at 4 J/m
 
2
 
 to a plateau
of 
 
 
 
15% at 16 J/m
 
2
 
 (Fig. 5 B). A similar UV dose-depen-
dent immobilization was observed with core NER fac-
tors, such as ERCC1-GFP–XPF (Houtsmuller et al.,
1999), GFP-XPA (Rademakers et al., 2003), and TFIIH-GFP
(Hoogstraten et al., 2002), although the maximum fraction
of GFP-CSB immobilization (
 
 
 
15%) is significantly lower
than found with the other NER factors (35–40%). No UV-
induced immobilization was found with non-NER factors
tagged with GFP (Houtsmuller et al., 1999) stressing the
notion that immobilization is related to NER. This suggests
that GFP-CSB binds more stably to stalled RNAP II than to
elongating RNAP II.
When prolonged immobilization is dependent on stalled
polymerases, and implicitly on TCR, we predict that the
UV-induced immobilization requires active transcription.
To verify this hypothesis we treated the cells with the tran-
scription inhibitor DRB before UV irradiation. As shown in
the mobility plot of Fig. 5 C (green line) a significant de-
crease of the immobile fraction upon transcriptional inhibi-
tion was apparent when compared with transcriptional ac-
tive UV-irradiated cells (DRB did not completely prevent
UV-induced immobilization, likely caused by incomplete
transcription inhibition). This indicates that the observed
immobilization of GFP-CSB is most likely due to its engage-
ment in TCR.
When the immobilization of CSB reflects actual participa-
tion in TCR we expect that the immobilized fraction would
decrease in time depending on progression of repair. There-
fore, we measured UV-dependent immobilization of GFP-
CSB molecules at various time points after irradiation (Fig.
5 D, 16 J/m
 
2
 
). These experiments revealed that the bound
fraction gradually decreased to background levels within 16 h
after UV. This indicates that UV-dependent immobiliza-
tion of GFP-CSB is a reversible process. Interestingly, the
kinetics of this process was much slower than anticipated on
the basis of the efficient damage repair by TCR measured in
selected genes (Mellon et al., 1987).
 
GFP-CSB mobility in NER-deficient (XP-A) cells
 
To investigate the effect of defective DNA repair on the
mobility of GFP-CSB we examined UV-induced immobi-
lization in repair deficient cells, lacking functional XPA
(XP12RO). Comparative analysis of FRAP experiments
applied to cells expressing GFP-CSB in either CSB- or
XPA-deficient cells showed a slightly larger immobile
fraction of CSB molecules in XPA cells upon UV irradia-
tion, using a subsaturating UV dose of 8 J/m
 
2
 
 (Fig. 6, A
and B). This contrasts to UV treatment after transcription
Figure 4. In vitro transcriptional activity of CSB-associated RNA 
polymerase II. RNAP II transcriptional activity is present in the 2tCSB 
HA-eluate. In vitro transcription was performed in a reconstituted tran-
scription system (RTS) containing human recombinant TBP, TFIIB, 
TFIIE, and highly purified HeLa TFIIH, TFIIF, and RNAP II and the 
adenovirus major late promoter as a template (309 nt). Lanes 1 and 
8 show complete reactions. To determine the presence of transcrip-
tion components in the tagged-CSB fraction, individual transcription 
factors (indicated on top of each lane) were omitted from reactions 
containing HA-eluate from 2tCSB WCE (lanes 2 and 3 and lanes 
9–14). As a control, HA-eluate from HeLa WCE (lanes 4 and 5), 
or no protein (lanes 6 and 7) were added to reactions lacking TBP 
or RNAP II.
Figure 5. FRAP analysis of GFP-CSB after UV irradiation. (A) FRAP 
analysis of untreated cells (blue line; n   148) and UV-irradiated 
cells (16 J/m
2; red line; n   125). GFP-CSB mobility in UV-treated 
cells is measured between 5 and 25 min after irradiation. UV-treated 
cells show an immobilization of GFP-CSB. (B) Dose dependency of 
GFP-CSB immobilization based on three independent experiments. 
(C) FRAP analysis of untreated cells (blue line; n   148), cells treated 
with DRB before UV irradiation (16 J/m
2; green line; n   79) and 
cells treated with UV solely (16 J/m
2; red line; n   125). DRB was 
added to the medium 3 h before the experiment. (D) Dynamics of 
the immobile fraction of GFP-CSB in time after UV (16 J/m
2) based 
on three independent experiments. 
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inhibition, where a smaller immobilized fraction was ob-
served (Fig. 5 C). Importantly and in contrast to GFP-
CSB molecules in repair proficient cells (Fig. 6 C and Fig.
5 B), the fraction of immobilization in XPA-deficient cells
did not decrease (nor increase) 4 h after UV-damage in-
duction (Fig. 6 D). The notion that the fraction of im-
mobilized molecules is not substantially increased as
compared with NER-proficient cells, suggest that CSB
molecules are not permanently trapped in repair complexes,
but transiently interact with blocked polymerases. This
transient interaction with abortive repair complexes is sig-
nificantly different from the stable association of CSB
with stalled RNAP II by Actinomycin D treatment (Fig. 3 C;
Kimura et al., 2002).
 
GFP-CSB accumulates at sites of local damage
 
DNA damage-dependent immobilization of GFP-CSB ar-
gues for a model in which CSB complexes that transiently
interact with the transcription machinery remain longer
bound to lesion-blocked polymerases than to elongating
complexes. To obtain further evidence for this hypothesis we
locally inflicted UV lesions in cells expressing GFP-CSB us-
ing a porous UV-blocking membrane (Volker et al., 2001).
Shortly after UV irradiation, we detected accumulations of
GFP-CSB similar to those found for other NER proteins
such as XPA (Fig. 7 A). XPA is involved in GGR and TCR
and is known to accumulate at locally damaged areas in the
cell (Volker et al., 2001; Rademakers et al., 2003). This in-
dicates that GFP-CSB also accumulates at sites of DNA
damage, most likely active in TCR. Interestingly, the num-
ber of accumulated GFP-CSB molecules in the damaged
area is relatively stable at least up to 8 h after UV (Fig. 7 A).
These results are in line with our findings that upon overall
UV irradiation an immobilization of GFP-CSB is measured
until 16 h after UV. This is in contrast to XPA, which
showed an intense concentration of proteins a few minutes
after UV that in the first 2 h drops to a lower steady-state
level (2 h after UV irradiation) and then slowly reduces to-
ward background levels. In addition, immunofluorescence
analysis showed that 6-4PPs are removed within 2 h after
UV, whereas the vast majority of CPD lesions are still
present up to 8 h after local irradiation (Volker et al., 2001;
unpublished data). This suggests that the early intense accu-
mulation of XPA mainly reflects repair of 6-4PPs via the
GGR pathway, whereas the subsequent less intense accumu-
lation of XPA represents repair of CPDs.
Do these local accumulations reflect long-term (a few
hours) immobilization of CSB molecules or are they the re-
sult of a dynamic equilibrium between binding and releasing
molecules at the site of damage? To investigate this, we de-
termined the GFP-CSB residence time in the accumulations
by FRAP on damaged and nondamaged areas in the nucleus.
For this purpose we bleached the fluorescence in the locally
damaged region. Interestingly, a quick recovery of fluores-
cence within the local damaged area was observed (Fig. 7 B),
indicating that repair-bound GFP-CSB molecules rapidly
exchange with the mobile pool. However, the fluorescence
recovery in the damaged area is slower than in an equally
sized control region in a nondamaged cell (Fig. 7 B). We cal-
culated an average residence time of GFP-CSB molecules in
the local damage of 135 
 
 
 
 20 s. This binding time is short
relative to other core NER factors like XPA, TFIIH, and
ERCC1, which are bound in a locally damaged area for 3–5
min (Houtsmuller et al., 1999; Hoogstraten et al., 2002;
Rademakers et al., 2003).
 
Discussion
 
Here, we present a study on the dynamic behavior of the
TCR protein CSB in living cells, using a cell line that stably
expresses functional GFP-tagged CSB protein at physiologi-
cal levels. Confocal microscopy and quantitative digital im-
age analysis of different photobleaching (FRAP) procedures
revealed transient interactions of CSB with the transcription
machinery, which are prolonged when RNA polymerases are
arrested at sites of DNA damage.
 
Mobility of GFP-CSB
 
FRAP analysis indicated that the overall CSB mobility is re-
markably slow compared with its calculated molecular size
and the observed effective diffusion rate (
 
D
 
eff
 
) of other NER-
factors (XPA, ERCC1–XPF, and TFIIH) tested in a similar
fashion that all have a 
 
D
 
eff
 
 that is in concordance with their
molecular sizes, arguing against a stable preassembled NER
“holo” complex (Houtsmuller et al., 1999; Hoogstraten et
al., 2002; Rademakers et al., 2003). The relatively slow mo-
bility of GFP-CSB in vivo, even in transcription inhibited
cells, confirms previous biochemical evidence that CSB re-
sides in a complex with an estimated hydrodynamic velocity
of particles 
 
 
 
700 kD (van Gool et al., 1997).
Figure 6. FRAP analysis of GFP-CSB in NER-deficient (XP group A) 
cells. (A) FRAP curves of untreated (blue line; n   20) and 8 J/m
2 
UV-irradiated (red line; n   20) GFP-CSB–expressing CS1AN cells, 
measured between 5 and 15 min after UV irradiation. 8 J/m
2 induced 
a smaller immobile fraction as 16 J/m
2 as shown in Fig. 5 A. (B) 
Identical to A, however here GFP-CSB is expressed in XP group A 
cells, lacking functional NER. A slight increase in the immobile fraction 
is visible as compared with repair-proficient cells in A. (C and D) 
Identical to A and B, respectively, with the exception that here also 
the FRAP measurements were plotted that were performed 4 h after 
UV irradiation (green lines, n   200), with an intermediate immobi-
lization in NER-proficient cells and no recovery of the immobilized 
fraction in XP-A cells. 
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Dynamic interactions of CSB with the 
transcription machinery
 
A significant fraction (
 
 
 
25%) of RNAP II in mammalian
cells is bound to DNA and a single polymerase typically is
bound for 
 
 
 
20 min during transcription elongation (Ki-
mura et al., 2002). The suggested role of CSB in tran-
scription elongation predicts that CSB-containing com-
plexes show similar dynamics as RNAP II. However, FRAP
studies suggest that only a small fraction of CSB-containing
complexes (
 
 
 
17%) are immobilized for 
 
 
 
2–5 s in a tran-
scription-dependent fashion. The drop in mobility at 27
 
 
 
C
as compared with 37
 
 
 
C suggests that CSB is immobilized in
a temperature-dependent fashion, most likely due to its in-
volvement in transcription. Interestingly, upon treatment
with Actinomycin D an unexpectedly large fraction of CSB
is immobilized. A similar strong immobilization, induced by
Actinomycin D treatment, was reported for GFP-tagged
RNAP II. The authors explain this observation by a perma-
nent block of the elongating complex caused by the DNA
intercalating agent (Kimura et al., 2002). Apparently, these
“frozen” complexes permanently trap CSB molecules. In
conclusion, our findings suggest a model in which there is a
dynamic equilibrium between mobile CSB complexes and
CSB transiently bound to elongating RNAP II.
Dynamic interactions of transcription factors with active
transcription sites have been noticed before using similar
procedures. Hager and colleagues (McNally et al., 2000)
described a rapid exchange between chromatin-bound and
freely mobile GFP-tagged glucocorticoid receptors. More-
over, our dynamic studies on GFP-tagged TFIIH and an-
drogen receptors (Hoogstraten et al., 2002; Farla et al.,
2004), revealed a similar short transcription-dependent in-
teraction. However, both factors stimulate transcription ini-
tiation rather than elongation (Chandler et al., 1983; Lu et
al., 1992). Obviously, elongating complexes, by virtue of
their nature, are longer associated to DNA than we observe
here for CSB. The transient interactions of elongation stim-
ulating factors, such as CSB, may provide a flexible response
to different chromatin conformations or changing condi-
tions during elongation allowing different factors to bind on
demand. This is the first in vivo example of a transcription
elongation factor that is not a stably associated component
of the RNAP II elongation holocomplex.
Previously, a fraction of CSB molecules was found to in-
teract with RNAP II (Tantin et al., 1997; van Gool et al.,
1997). In addition, recombinant CSB was claimed to stimu-
late RNAP II elongation in vitro (Selby and Sancar, 1997)
and RNAP II transcription was reported to be slightly im-
paired in CSB-deficient cells (Balajee et al., 1997; Dianov et
al., 1997). Furthermore, a specific role in transcription elon-
gation for the Rad26 protein (the yeast homologue of CSB)
was found in yeast (Lee et al., 2001) and deduced from ge-
netic interactions between Rad26 and Spt4 (Jansen et al.,
2000), which is implicated in regulation of RNAP II proces-
sivity (Hartzog et al., 1998; Wada et al., 1998). Here, we
demonstrate that in a reconstituted transcription assay CSB-
associated RNAP II is transcriptionally competent. No other
general transcription initiation factors were detected in the
immunoprecipitated fraction. Together, these studies sup-
port a role for CSB in transcription elongation.
Figure 7. Accumulation of GFP-CSB at local 
UV-damaged subnuclear areas. (A) Epifluorescent 
images of fixed GFP-CSB–expressing cells at various 
time points (15 min, 2 h, 4 h, 8 h) after local irradi-
ation. Immunofluorescent analysis with anti-XPA 
antibody shows accumulation of XPA at sites of 
damage. GFP-CSB shows accumulation in the 
same areas. Top, GFP signal; bottom, Cy3 signal. 
The arrows all point to UV-induced local accumu-
lations of GFP-CSB and XPA, respectively. Bar, 5  m. 
(B) Fluorescence recovery plot of a local damage 
(red diamonds) and an undamaged control region 
(blue circles). The calculated average residence 
time is 135   20 s. 
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Besides a function in RNAP II-driven transcription, a more
general role for CSB in RNA polymerase I and III mediated
transcription was suggested (Yu et al., 2000; Bradsher et al.,
2002). The nucleolar localization of GFP-CSB in vivo pre-
sented here supports a role of CSB in processivity of other
RNA polymerases. Furthermore, the absence of the CSB pro-
tein in human fibroblasts derived from CS group B patients
caused fragility of metaphase chromosomes at specific loci,
these include the U1 and U2 snRNA genes (RNAP II) and
the 5S RNA genes (transcribed by RNAP III; Yu et al., 2000).
It was suggested that this fragility is provoked by the absence
of a (general) stimulating function of CSB in elongation dur-
ing transcription of these highly structured RNAs.
 
Participation of CSB in TCR
 
The fraction of immobilized molecules after UV irradiation
decreased to background levels (
 
 
 
16 h) much slower than
core NER factors appeared to decrease to background levels
in 4–6 h after UV (Houtsmuller et al., 1999; Hoogstraten et
al., 2002; Rademakers et al., 2003). These kinetics of core
NER factors were similar to the rate of 6-4PP removal (Van
Hoffen et al., 1995) and thus suggest that with the applied
methods predominantly repair of 6-4PP was monitored.
DNA repair of the most abundant UV lesion, CPD, ap-
peared to occur at much slower rates. Repair of these lesions
mainly happens in the transcribed strand of active genes by
TCR, in contrast to 6-4PP removal that are almost as effi-
ciently repaired by GGR as by TCR (Van Hoffen et al.,
1995). Assuming that our observed immobilizations of GFP-
CSB actually reflect participation in TCR, this further im-
plies that completion of TCR is slower than completion of
the bulk of GGR. However, this assumption contrasts to the
general accepted model that TCR is more efficient than
GGR (Bohr et al., 1985; Mellon et al., 1987). A possible ex-
planation for this apparent contradiction is that the relatively
fast removal of CPDs by TCR was measured on frequently
transcribed genes (i.e.,
 
 DHFR), whereas our live cell studies
are performed on the total pool of transcriptional units, in-
cluding long and less frequently transcribed genes. Because
TCR is likely initiated by the blockage of transcription elon-
gation on lesions, the efficiency of TCR-dependent lesion re-
moval (such as CPDs) is likely determined both by the rate
of transcription and the size of the transcriptional unit.
In addition, similar to FRAP analysis, the local accumula-
tion of CSB was observed at least until 8 h after UV irradia-
tion, further providing evidence for a relatively long lasting
active TCR pathway after UV irradiation.
Dynamic interaction of CSB with TCR complexes
The relative small increase in immobilized GFP-CSB fraction
in XPA-deficient cells as compared with NER-proficient cells
and the fact that this fraction does not increase in time after
UV, suggest that CSB molecules are not permanently bound
to lesion-stalled RNAPII complexes that are not further pro-
cessed because of defective NER. It is remarkable that the ab-
sence of repair does not lead to a complete immobilization as
observed after treatment with Actinomycin D RNAPII
(Fig. 3 C). The DNA intercalating drug Actinomycin D
forms a permanent block for RNAPII thereby capturing the
molecule in a template-bound form (Kamitori and Takusagawa,
1992). In contrast, UV-induced stalling of RNAPII in an
XPA-deficient background probably induces a different type
of conformation which is still permissive to removal from the
DNA template by CSB. Evidence for the accessibility of
RNAPII stalled on UV lesions was very recently provided by
Tremeau-Bravard et al. (2004). This different behavior of
CSB might be explained by differential structural conse-
quences for the stalled RNAPII provoked by Actinomycin D
adducts versus bonafide NER lesions such as CPDs. Actino-
mycin D adducts do have a distinct effect on the DNA struc-
ture as compared with NER lesions because this drug does
not induce NER (unpublished data).
In addition, lesion-stalled polymerases are targets for
ubiquitination (Bregman et al., 1996) and, at least in yeast,
proteolysis of polyubiquitinated Rpb1 (largest RNAPII sub-
unit) by Def1 (Woudstra et al., 2002) plays a role in clearing
of stalled RNAPII from the lesion. This process provides an
escape route when Rad26 (yeast orthologue of CSB) is ex-
hausted or not present (van den Boom et al., 2002; Woud-
stra et al., 2002). If a similar system would be present in
mammalian cells this would provide an explanation that
UV-induced RNAPII are cleared in a Def1-dependent fash-
ion, and do not likely form such permanent roadblocks as
Actinomycin D.
Distinct kinetic pools of CSB
Here, we have shown that the equilibrium between different
kinetic pools of freely diffusing CSB complexes and a “tran-
scription bound” fraction can shift under different transcrip-
tional conditions. The observed temperature dependence of
CSB mobility might be due to its ATPase function during
association in transcription. Because CSB is essential for
TCR, we investigated the consequences of DNA damage on
the distribution of CSB over the distinct kinetic pools.
Shortly after UV exposure we observed a change in the dura-
tion of the transcription-related immobilization of CSB.
The maximal immobilization of  15% in TCR is signifi-
cantly smaller than the GGR-induced maximal immobiliza-
tion of  40% for other (core) NER factors (Houtsmuller et
al., 1999; Hoogstraten et al., 2002; Rademakers et al.,
2003). This implies that the molecular equilibrium, which is
established between DNA damage bound and freely diffus-
ing molecules, is different for GGR and TCR. Probably, the
immobile fraction of GGR proteins is directly dependent on
the DNA damage load, whereas the number of stalled
RNAP II elongation complexes in a cell determines the im-
mobile fraction of TCR proteins.
In summary, we find that CSB complexes transiently inter-
act with the transcription machinery during elongation. A
possible explanation for this behavior of CSB is that this pro-
tein constantly monitors the elongation status of the tran-
scribing polymerases. When a complex is stalled on a DNA
lesion the transient interactions of the CSB protein are stabi-
lized, to allow CSB to exert its function in damage removal.
Materials and methods
Generation and characterization of GFP-CSB fusion protein
To generate the GFP-CSB fusion gene, the NH2-terminal HA-tagged CSB
cDNA (van Gool et al., 1997) was cloned downstream of the GFP cDNAIn vivo dynamics of CSB | van den Boom et al. 35
in the SacI–SalI sites of the pEGFP-C3 expression vector (CLONTECH Lab-
oratories, Inc.). GFP-CSB was stably expressed in CS-B–deficient human fi-
broblasts (CS1AN-Sv) using SuperFect transfection reagent (QIAGEN). Af-
ter selection with 300  g/ml G418, stable transfectants were isolated and
selected for UV resistance by exposing cells three times to a UV dose of 4
J/m
2 UV-C (254 nm) with daily intervals. Stably expressing clones were
characterized for protein expression by immunoblot analysis using an af-
finity-purified rabbit polyclonal anti-CSB and by UV survival together with
VH10-Sv (wt) and untransfected CS1AN-Sv fibroblasts as described previ-
ously (van Gool et al., 1997).
Cell culture and specific treatments
The human fibroblasts CS1AN-Sv (CS-B), XP12RO-Sv (XP-A), and wild-
type VH10-Sv were grown in a 1:1 mixture of Ham’s F10 and DME
(GIBCO BRL) supplemented with antibiotics and 10% FCS at 37 C, 5%
CO2. Transcription inhibitors were used according to the following condi-
tions: 100  M N-(2[methylamino]ethyl)-5-isoquinolinesulfonamide (H8;
2 h), 10  g /ml Actinomycin D (2 h). Treatment with UV light was at 254
nm (UV-C) using a germicidal lamp at the indicated doses. DNA damage
in localized areas of the nucleus was performed as described previously
(Volker et al., 2001). For azide treatment cells were cultured for 15 min in
glucose-free medium (GIBCO BRL) supplemented with 60 mM deoxyglu-
cose and 0.2% Na-azide.
Light microscopy and image analysis
Cells were cultured on sterile glass coverslips. For indirect immunofluores-
cence, fixation was in 2% PFA in PBS for 10 min at RT. After fixation, cells
were permeabilized with 0.1% Triton X-100 in PBS. Endogenous CSB in
wild-type VH10-Sv cells was detected with affinity-purified, rabbit poly-
clonal anti-CSB. Secondary antibody staining was performed with anti–
rabbit Alexa 594–conjugated antibodies (Molecular Probes). For fixed
cells, fluorescent microscopy images were obtained with a Leitz Aristoplan
microscope equipped with epifluorescence optics and a PLANAPO 63X/
1.40 oil immersion lens. Confocal laser scanning microscopy images of
live cells were recorded with a LSM 410 (Carl Zeiss MicroImaging, Inc.).
GFP images were obtained after excitation with 455–490 and long pass
emission filter ( 510 nm). Alexa 595 images were obtained after excita-
tion with 515–560 and long pass emission filter (580 nm).
In vitro transcription assay
Transcription was assayed in an RTS-containing human recombinant TBP,
TFIIB, and TFIIE and purified HeLa TFIIA, TFIIF, TFIIH, and RNAP II as de-
scribed previously (Gerard et al., 1991). In brief, HA-elution fractions con-
taining CSB were preincubated with the indicated transcription factors and
with 100 ng of the adenovirus two major late promoter (Ad2MLP)-contain-
ing template for 15 min at 25 C. After the addition of nucleotides, tran-
scription was allowed to proceed for 45 min at 25 C. The 309 nt  -[
32P]-
CTP run off transcripts were resolved by electrophoresis through a 5%
acrylamide/50% urea gel and analyzed by autoradiography.
FRAP
A LSM410 (Carl Zeiss MicroImaging, Inc.) was used for the FRAP experi-
ments. Recovery curves for evaluation of protein mobility were obtained
as described previously (Hoogstraten et al., 2002). For FRAP analysis, a
2- m wide strip, spanning the entire nucleus, was bleached for 200 ms at
highest intensity of the 488-nm line of a 15-mW Ar-laser focused by a 40X
1.3 NA oil immersion lens. Subsequently, the recovery of fluorescence in
the strip was monitored at intervals of 100 ms with the same laser at 5% of
the intensity applied for bleaching, using a dichroic beamsplitter (488/
543 nm) and an additional 515–540 nm band pass filter for emission de-
tection. Similarly, combined FLIP and FRAP analysis was performed by
giving a 6-s bleach pulse to a strip at the bottom side of the cell. Next, the
fluorescent images were made with low laser intensity every 6 s for a to-
tal of 3 min.
Computer simulation
For optimal interpretation of the FRAP data we developed a computer
modeling environment to simulate FRAP applied to fluorescent molecules
inside a finite volume. The FRAP procedures were simulated using experi-
mentally obtained parameters describing lens (beam shape and 3-D inten-
sity distribution, during monitoring and bleach pulse), GFP (quantum
yield, susceptibility to bleaching), and nuclear properties (size and shape).
Three protein mobility parameters, diffusion coefficient, bound fraction,
and duration of binding of individual molecules were varied and the best
fit with experimental data was obtained using least square fitting.
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